Preclinical evaluation of chimeric antigen receptors targeting CD70-expressing cancers

QJ Wang, Z Yu, K Hanada, K Patel, D Kleiner… - Clinical Cancer …, 2017 - AACR
Purpose: CD70 expression in normal tissues is restricted to activated lymphoid tissues.
Targeting CD70 on CD70-expressing tumors could mediate “on-target, off-tumor” toxicity …
被引用次数：94 相关文章

Preclinical Evaluation of Chimeric Antigen Receptors Targeting CD70-Expressing Cancers

QJ Wang, Z Yu, KI Hanada, K Patel… - … : an official journal …, 2017 - pubmed.ncbi.nlm.nih.gov
Purpose: CD70 expression in normal tissues is restricted to activated lymphoid tissues.
Targeting CD70 on CD70-expressing tumors could mediate" on-target, off-tumor" toxicity …

Preclinical Evaluation of Chimeric Antigen Receptors Targeting CD70-Expressing Cancers

QJ Wang, Z Yu, K Hanada, K Patel, D Kleiner… - Clinical Cancer …, 2017 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> Purpose: CD70 expression in normal tissues is
restricted to activated lymphoid tissues. Targeting CD70 on CD70-expressing tumors could …

Preclinical Evaluation of Chimeric Antigen Receptors Targeting CD70-Expressing Cancers.

QJ Wang, Z Yu, KI Hanada, K Patel… - … Cancer Research: an …, 2016 - europepmc.org
Purpose: CD70 expression in normal tissues is restricted to activated lymphoid tissues.
Targeting CD70 on CD70-expressing tumors could mediate" on-target, off-tumor" toxicity …
[HTML] nih.gov

[HTML][HTML] Pre-clinical Evaluation of Chimeric Antigen Receptors Targeting CD70-Expressing Cancers

QJ Wang, Z Yu, K Hanada, K Patel… - … cancer research: an …, 2017 - ncbi.nlm.nih.gov
Purpose CD70 expression in normal tissues is restricted to activated lymphoid tissues.
Targeting CD70 on CD70-expressing tumors could mediate “on-target, off-tumor” toxicity …

Preclinical Evaluation of Chimeric Antigen Receptors Targeting CD70-Expressing Cancers.

QJ Wang, Z Yu, KI Hanada, K Patel… - … Cancer Research: an …, 2016 - europepmc.org
Purpose: CD70 expression in normal tissues is restricted to activated lymphoid tissues.
Targeting CD70 on CD70-expressing tumors could mediate" on-target, off-tumor" toxicity …